DE69942575D1 - Nukleinsäuremolekül, die für die alpha-kettedes pferde-fc-epsilon-rezeptors kodieren, korrespondierende proteine und ihre verwendungen - Google Patents

Nukleinsäuremolekül, die für die alpha-kettedes pferde-fc-epsilon-rezeptors kodieren, korrespondierende proteine und ihre verwendungen

Info

Publication number
DE69942575D1
DE69942575D1 DE69942575T DE69942575T DE69942575D1 DE 69942575 D1 DE69942575 D1 DE 69942575D1 DE 69942575 T DE69942575 T DE 69942575T DE 69942575 T DE69942575 T DE 69942575T DE 69942575 D1 DE69942575 D1 DE 69942575D1
Authority
DE
Germany
Prior art keywords
nucleic acid
proteins
epsilon receptor
mollows
ketted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69942575T
Other languages
English (en)
Inventor
Eric R Weber
Catherine A Mccall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heska Corp
Original Assignee
Heska Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heska Corp filed Critical Heska Corp
Application granted granted Critical
Publication of DE69942575D1 publication Critical patent/DE69942575D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/862—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgE or IgD
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69942575T 1998-01-29 1999-01-28 Nukleinsäuremolekül, die für die alpha-kettedes pferde-fc-epsilon-rezeptors kodieren, korrespondierende proteine und ihre verwendungen Expired - Lifetime DE69942575D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/015,734 US6057127A (en) 1998-01-29 1998-01-29 Equine Fc epsilon receptor alpha chain nucleic acid molecules and uses thereof
PCT/US1999/001903 WO1999038974A1 (en) 1998-01-29 1999-01-28 EQUINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, CORRESPONDING PROTEINS AND USES THEREOF

Publications (1)

Publication Number Publication Date
DE69942575D1 true DE69942575D1 (de) 2010-08-26

Family

ID=21773286

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69942575T Expired - Lifetime DE69942575D1 (de) 1998-01-29 1999-01-28 Nukleinsäuremolekül, die für die alpha-kettedes pferde-fc-epsilon-rezeptors kodieren, korrespondierende proteine und ihre verwendungen

Country Status (10)

Country Link
US (5) US6057127A (de)
EP (1) EP1051491B1 (de)
AT (1) ATE474047T1 (de)
AU (1) AU746218B2 (de)
CA (1) CA2319310C (de)
DE (1) DE69942575D1 (de)
DK (1) DK1051491T3 (de)
ES (1) ES2348971T3 (de)
PT (1) PT1051491E (de)
WO (1) WO1999038974A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057127A (en) * 1998-01-29 2000-05-02 Heska Corporation Equine Fc epsilon receptor alpha chain nucleic acid molecules and uses thereof
WO2001029078A2 (en) 1999-10-15 2001-04-26 Heska Corporation Method for production and use of mite group 1 proteins
US6889145B1 (en) 2000-03-15 2005-05-03 Northwestern University Three-dimensional model of a Fc region of an IgE antibody and uses thereof
AU2001273456A1 (en) * 2000-07-13 2002-01-30 Hyseq, Inc. Soluble immunoglobulin e receptor alpha like molecules
US6916626B1 (en) * 2001-04-25 2005-07-12 Rockeby Biomed Ltd. Detection of Candida
US6753303B2 (en) * 2001-12-06 2004-06-22 Hershey Entertainment & Resorts Company Whipped cocoa bath
EP2567973B1 (de) * 2005-11-28 2014-05-14 Zymogenetics, Inc. IL-21-Antagonisten
BRPI0806474A2 (pt) * 2007-01-09 2011-09-27 Mystic Pharmaceuticals Inc dispositivos de cartucho intranasal
EP2373579A2 (de) * 2008-12-08 2011-10-12 Tisol, Llc Mehrkomponentige nanopartikelmaterialien und verfahren und vorrichtung dafür
WO2017094027A1 (en) * 2015-12-01 2017-06-08 Cipla Limited Nasal spray assembly
EP3192806A1 (de) 2016-01-13 2017-07-19 Affiris AG Alpha-kette des hochaffinen ige-rezeptors (fceria)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956752A (en) * 1975-03-12 1976-05-11 Harris Corporation Polarization insensitive lens formed of spiral radiators
US4962035A (en) * 1987-12-01 1990-10-09 President And Fellows Of Harvard College DNA encoding IgE receptor alpha-subunit or fragment thereof
CA2000878C (en) * 1988-10-18 1999-06-29 Jean-Pierre Kinet Cdnas coding for the subunit of the high-affinity receptor for immunoglobulin e
WO1991006570A1 (en) * 1989-10-25 1991-05-16 The University Of Melbourne HYBRID Fc RECEPTOR MOLECULES
WO1993004173A1 (en) * 1991-08-14 1993-03-04 Genentech, Inc. Immunoglobulin variants for specific fc epsilon receptors
US5965709A (en) * 1991-08-14 1999-10-12 Genentech, Inc. IgE antagonists
US5770396A (en) * 1992-04-16 1998-06-23 The United States Of America As Represented By The Department Of Health And Human Services Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E
FR2697485B1 (fr) * 1992-11-02 1995-01-20 Valeo Vision Feu de signalisation à éléments lumineux modulaires, pour véhicule automobile.
US5945294A (en) * 1996-11-26 1999-08-31 Heska Corporation Method to detect IgE
US5958880A (en) * 1996-12-19 1999-09-28 Heska Corporation Feline Fc epsilon receptor alpha chain proteins and therapeutic uses thereof
US6057127A (en) * 1998-01-29 2000-05-02 Heska Corporation Equine Fc epsilon receptor alpha chain nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
US20050170466A1 (en) 2005-08-04
AU2567499A (en) 1999-08-16
EP1051491B1 (de) 2010-07-14
CA2319310C (en) 2011-05-24
US7226996B2 (en) 2007-06-05
US6582701B1 (en) 2003-06-24
CA2319310A1 (en) 1999-08-05
DK1051491T3 (da) 2010-08-16
ES2348971T3 (es) 2010-12-17
US6057127A (en) 2000-05-02
WO1999038974A1 (en) 1999-08-05
EP1051491A1 (de) 2000-11-15
ATE474047T1 (de) 2010-07-15
AU746218B2 (en) 2002-04-18
PT1051491E (pt) 2010-08-20
US20070238196A1 (en) 2007-10-11
US20030235579A1 (en) 2003-12-25
US6887672B2 (en) 2005-05-03

Similar Documents

Publication Publication Date Title
BRPI0408247A (pt) usos de antagonistas e agonistas de il-23 e reagentes relacionados
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
WO2005005462A3 (en) Blys antagonists and uses thereof
DE60314500D1 (de) Diaminopyrimidine und deren verwendung als angiogenesehemmer
DE602004024572D1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
ATE382053T1 (de) System zur antikörperexpression und- synthese
DE69824597D1 (de) Ikk-beta proteine, nukleinsäuren und verfahren
ATE530911T1 (de) Bindungsproteine als biosensoren
WO2005014035A3 (en) Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
CY1111070T1 (el) Παραγωγα 2-αμινο-κουιναζολινης χρησιμα ως αναστολεις της β-σεκρετασης (bace)
NO20064866L (no) IRTA-5 antistoffer og deres anvendelse
ATE504602T1 (de) Für humane matriptase spezifische bindungsproteine
DE69942575D1 (de) Nukleinsäuremolekül, die für die alpha-kettedes pferde-fc-epsilon-rezeptors kodieren, korrespondierende proteine und ihre verwendungen
DE60313004D1 (de) Alpha-7-nikotinsäure-rezeptoragonisten und statine in kombination
ATE417605T1 (de) Proteine die cross-beta-struktur enthaltendes amyloid binden, sowie verfahren zur modulation der cross-beta-struktur, ihrer bildung und der damit zusammenhängenden toxizität
ATE291621T1 (de) Nukleinsaeuren und proteine der katze fc-epsilon rezeptor alpha-kette und deren verwendungen
DE69826493D1 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
MXPA05011085A (es) Composiciones y metodos relacionados a stop-1.
MXPA04005992A (es) Derivados de acido 3-fenil-2-arilalquiltiopropionico como antagonistas selectivos de ppar-alfa.
IL177915A0 (en) Fluorescence polarization assay
DE69507017D1 (de) Cai-resistenzproteine kodierende dna, und ihre verwendung
WO2002102852A3 (en) Modified cd8 molecule, nucleic acid encoding said molecule, and their therapeut ic use
ATE420162T1 (de) Verfahren und zusammensetzungen zum targeting sekretorischer lysosomen
ATE298244T1 (de) Monoklonaler antikörper mit selektiver bindung an vgf und verwendung zur behandlung von vgf- erkrankungen
ATE437846T1 (de) Cyclooct-(en-)yl-derivate zur verwendung als duftstoffe

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: HESKA CORP., LOVELAND, COL., US